Determining the survival benefit of adjuvant radiotherapy in patients with node-positive head and neck cancer

Giuseppe Sanguineti, Arlene Forastiere

Postoperative radiotherapy with or without chemotherapy remains part of the standard treatment regimen to improve locoregional control for patients with head and neck cancer who have adverse pathologic factors after surgery. Whether an overall survival benefit can be expected remains unclear.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1